Informational bulletin «Cardioprogress»

Informational bulletin «Cardioprogress»

Bulletin is published four times a year in both Russian and English (special issues) languages. 

It highlights the international and Russian scientific-practical conferences and events, opinion of experts on the issues of cardiology and public health, interviews with leading experts and news. In the pages of the bulletin the latest advances in medical technology, equipment and drug development are presented. 

The addressed spreading is free (Ministry of Health of the republics and regions of Russia, city health committees, medical universities, research institutes and specialized medical institutions, hospitals in Russia and CIS).

Contacts

Cardioprogress Foundation and Editorial Office:
Room 213, Building 2, Prospect Gostinichny 6, Moscow 127106, Russia Editorial Office
tel.: (+7) 965 236 1600 Official website: www.cardioprogress.ru
Editorial correspondence should be sent to:
Mehman Mamedov, Deputy Editor
editor.ihvdj@gmail.com

Issues

Scientific news

  • CPAP Boosts Testosterone in Obesity-Related Hypogonadism Severe or decompensated obstructive sleep apnoea syndrome (OSAS) was significantly associated with functional hypogonadism in men with severe obesity. Continuous positive airway pressure (CPAP) therapy, monitored using overnight pulse oximetry, improved testosterone levels in newly diagnosed patients with OSAS.
  • Inexpensive Anti-Inflammatory Pill Could Reduce Risk of Heart Attack and Stroke A commonly used and affordable medication for gout may help lower the risk of heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
  • Scientists have discovered a diet that influences the development of cardiovascular diseases Researchers discovered that a nutrient-matched, plant-based diet could prevent and reverse a hidden form of heart disease in hypertensive rats. The research, published in the Journal of the American Heart Association, explored whether coronary microvascular dysfunction (CMD) could be lessened in hypertensive rats.
  • GLP-1s Pose Heart Risks in Patients With HFrEF and Implants Patients with heart failure with reduced ejection fraction (HFrEF) and implanted cardiac devices who used GLP-1 receptor agonists had higher heart rates, greater number of nonsustained ventricular tachycardia events, and higher levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) than those who did not use the drugs.
  • Left Atrial Appendage Occlusion May Lower Stroke Severity Left atrial appendage occlusion (LAAO) during cardiac surgery in patients with atrial fibrillation was associated with lower stroke-related disability and reduced risk for 30-day mortality and cardioembolic stroke than standard care, new research showed.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru